Trypanocidal Trixikingolides From Trixis Vauthieri
2021
Sales Junior, Policarpo Ademar | Zani, Carlos Leomar | de Siqueira, Ezequias Pessoa | Kohlhoff, Markus | Marques, Fátima Regina | Caldeira, Alisson Samuel Portes | Cota, Betânia Barros | Maia, Daniela Nabak Bueno | Tunes, Luiza Guimarães | Murta, Silvane Maria Fonseca | Alves, Tânia Maria Almeida
Chagas disease is an illness caused by the protozoan parasite Trypanosoma cruzi. Only two drugs are available, with the drawback of low rate of cure in the chronic phase of the disease and undesirable side effects. These facts highlight the need to find new compounds for Chagas disease chemotherapy. We describe the isolation and identification of an inseparable mixture of two new trixikingolides from Trixis vauthieri, a plant from family Asteraceae, which present outstanding in vitro trypanocidal activity, with IC₅₀ value of 0.053 µM against the intracellular trypomastigotes and amastigotes forms of T. cruzi infecting L929 cells. The IC₅₀ of the mixture against the host cells is 68 times higher and about 70 times more potent than benznidazole, the reference drug used as control at the experiments. The next step, which depends on obtaining larger quantities of the mixture, is to test it on mice infected with T. cruzi.
显示更多 [+] 显示较少 [-]